In our review, CRP was found to have low predictive utility with moderate strength of evidence, which may be due to variability in cut-offs used for this marker, the relatively small numbers of studies, differential effects in diabetes, or less sensitive to detect low-grade vascular inflammation (compared with hs-CRP). Here, CRP is linked to diabetes mellitus.